Parameter_Type	Parameters
Common_Inputs	Subject demographics (age, sex, height, weight, ethnicity); smoking status; respiratory diagnoses (asthma, COPD, CF, IPF); disease diagnosis and severity; disease phenotype; medication use and adherence; exposure history (environmental, occupational); spirometer type and calibration; technician training; quality control criteria (ATS/ERS acceptability and reproducibility); number of acceptable maneuvers; reference equations used; environmental conditions (temperature, humidity); study population; patient characteristics; biospecimen collection (blood, sputum, BALF); longitudinal follow-up schedule
Common_Exposure	Environmental or occupational exposures; bronchodilator administration (pre- and post-bronchodilator testing); CFTR modulators; inflammatory challenges; bronchial challenge tests (PC20 or PD20); sputum induction; FeNO measurement protocol; blood and exhaled breath condensate (EBC) collection; imaging (chest CT); biomarker assay platforms; omics data generation (genomics, transcriptomics, proteomics, metabolomics)
Common_Outputs	FEV1 (liters and % predicted); FVC (liters and % predicted); FEV1/FVC ratio; FEF25-75; Percent change from baseline; Bronchodilator response; Longitudinal decline rate (mL/year); Plethysmography (TLC, RV, FRC); DLCO (diffusing capacity); FeNO (fractional exhaled nitric oxide); Bronchial hyperresponsiveness (PC20 or PD20); Exacerbation rates; Sputum or BALF inflammatory cell counts; Inflammatory mediator levels; Imaging findings (airway wall thickness, emphysema); Biomarker levels (cytokines, oxidative stress markers); Multi-omics signatures; Correlation coefficients; Predictive models for outcomes; Correlation with disease severity
